Lincoln Pharmaceuticals Ltd Share Price ₹636

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Lincoln Pharmaceuticals Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	112	136	156	146	142	147	161	147	168	154	163	166	187
Expenses +	96	115	125	117	124	125	133	123	141	130	138	143	162
Operating Profit	17	21	31	30	18	23	28	24	27	24	25	24	25
OPM %	15%	15%	20%	20%	13%	15%	18%	16%	16%	15%	16%	14%	13%
Other Income +	4	8	9	11	7	10	10	9	-7	15	7	15	-4
Interest	1	0	0	0	0	0	0	1	0	0	0	0	0
Depreciation	2	3	3	3	3	3	3	3	3	3	4	4	4
Profit before tax	17	25	37	38	22	29	35	29	16	35	29	35	17
Tax %	26%	25%	25%	26%	16%	20%	24%	28%	29%	22%	31%	18%	30%
Net Profit +	13	19	28	28	19	24	26	21	12	28	20	29	12
EPS in Rs	6.27	9.49	13.80	14.00	9.29	11.82	13.15	10.37	5.78	13.82	9.98	14.28	5.81

Financials of Lincoln Pharmaceuticals Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	266	400	360	361	366	386	424	472	510	581	623	671
Expenses +	240	359	313	308	299	321	337	376	421	480	522	573
Operating Profit	26	41	47	53	68	66	87	96	90	100	102	98
OPM %	10%	10%	13%	15%	18%	17%	21%	20%	18%	17%	16%	15%
Other Income +	7	7	2	5	5	11	5	10	22	34	22	33
Interest	8	10	7	5	4	2	2	1	2	1	2	1
Depreciation	5	5	6	6	7	7	8	8	9	11	13	14
Profit before tax	20	33	37	46	62	67	84	96	100	122	109	116
Tax %	24%	28%	25%	25%	22%	23%	26%	28%	27%	24%	25%	24%
Net Profit +	15	24	28	35	49	51	62	69	73	93	82	88
EPS in Rs	9.20	14.52	14.06	17.31	24.36	25.72	31.12	34.63	36.40	46.58	41.11	43.88
Dividend Payout %	11%	7%	9%	9%	6%	6%	5%	4%	4%	4%	4%	4%

Financials of Lincoln Pharmaceuticals Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	16	16	20	20	20	20	20	20	20	20	20	20
Reserves	95	124	172	204	249	293	346	413	482	573	652	738
Borrowings +	76	78	64	61	34	5	1	2	2	1	0	4
Other Liabilities +	70	56	48	62	63	71	85	99	83	106	125	128
Total Liabilities	258	275	305	347	366	389	452	534	587	700	797	890
Fixed Assets +	66	98	103	117	121	123	111	132	151	179	182	191
CWIP	3	3	7	0	2	0	2	16	7	3	4	5
Investments	0	0	10	11	18	34	81	97	91	139	174	209
Other Assets +	190	174	186	219	225	232	259	290	339	379	437	486
Total Assets	258	275	305	347	366	389	452	534	587	700	797	890

Financials of Lincoln Pharmaceuticals Ltd

Operating, investing and financing cash movement

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	25	45	25	27	53	75	69	76	39	63	93
Cash from Investing Activity +	7	-42	-25	-12	-18	-31	-64	-78	-37	-57	-79
Cash from Financing Activity +	-32	-3	0	-11	-36	-38	-6	-3	-4	-5	-6
Net Cash Flow	-1	-0	-0	3	-1	7	-1	-4	-2	1	8
Free Cash Flow	21	11	7	17	38	68	61	31	26	24	74
CFO/OP	109%	126%	74%	68%	104%	137%	102%	104%	77%	89%	117%

Financials of Lincoln Pharmaceuticals Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	163	73	92	111	122	96	98	90	98	102	97	88
Inventory Days	44	36	63	86	75	95	86	121	106	101	99	94
Days Payable	92	40	54	82	92	102	105	120	77	95	106	100
Cash Conversion Cycle	116	70	100	115	106	88	78	91	126	108	90	82
Working Capital Days	76	31	69	89	113	126	119	113	121	121	116	239
ROCE %	15%	21%	19%	19%	23%	22%	25%	24%	22%	22%	17%	16%